tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Leuchten, 6 are a BUY (30%), 11 are a HOLD (55%), 3 are a SELL (15%).
Analyst Michael Leuchten, currently employed at UBS, carries an average stock price target met ratio of 50% that have a potential upside of 11.99% achieved within 211 days.
Michael Leuchten’s has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 12-Jul-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 3/23/2020. The price target of $31.06 was fulfilled within 79 days with a profit of $7.79 (33.48%) receiving and performance score of 4.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87
$10.79 (14.16%)
$78
3 months 14 days ago
(18-Nov-2024)
8/9 (88.89%)
$23.61 (37.25%)
588
Buy
$88
$11.79 (15.47%)
$82
3 months 19 days ago
(13-Nov-2024)
4/5 (80%)
$22.71 (34.78%)
297
Buy
$95
$18.79 (24.66%)
$66
6 months 20 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
382
Buy
$85
$8.79 (11.53%)
$80
9 months 2 days ago
(30-May-2024)
4/4 (100%)
$8.7 (11.40%)
391
Buy
$84
$7.79 (10.22%)
$85
10 months 10 days ago
(22-Apr-2024)
2/12 (16.67%)
$14.3 (20.52%)
163
What Year was the first public recommendation made by Michael Leuchten?
